Back to Directory

Muse Cell Therapy

Multilineage-differentiating Stress Enduring cells

Visual ViewRaw Data

Meta Information

ID:muse-cell-therapy
Name:Muse Cell Therapy
Schema Version:1.5

Title

Muse Cell Therapy

Alternate Names

  • Multilineage-differentiating Stress Enduring cells

Intervention Type

procedure

Expected Cost Mean

Low Cost:
50000
High Cost:
150000
Cost Type:
one time
Description:
Estimated cost for a single treatment course within a clinical or specialized setting.

Summary

Muse cells are a unique type of naturally occurring, non-tumorigenic stem cell that can be collected from sources like bone marrow or adipose tissue. When administered, they selectively travel to sites of injury or inflammation to repair and regenerate damaged tissue. The healthspan hypothesis is that this therapy could systemically reverse age-related cellular damage, reduce chronic inflammation, and restore organ function.

Purpose

Endogenous stem cell therapy to repair damaged tissue and reduce inflammation.

Card Summary

A type of endogenous stem cell therapy that targets and repairs damaged tissues, potentially counteracting age-related degeneration.

Drug Class

Drugs In Class

Empty Array

Impact

Score:
3.8
Justification:
Theoretically high potential for systemic repair, but currently lacks human longevity data.

Evidence

Grade:
C
Score:
3.2
Justification:
Early human trials exist for specific diseases, but no healthspan or longevity studies.

Safety

Score:
7.5
Justification:
Invasive procedure with potential for infusion reactions and unknown long-term cellular effects.

Flags

  • Currently available only within clinical trials for specific indications like stroke or heart attack.
  • Not approved as a general anti-aging or healthspan therapy by any major regulatory body.
  • Long-term effects of systemic administration in healthy individuals are completely unknown.
  • Extremely high cost and very limited accessibility.

Verdict

A promising but highly experimental therapy, not ready for healthspan applications.

Created

2026-04-23T23:46:19.716584Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:
none
Scope:
  • systemic

Indication

Focus:
healthspan
Description:
Muse cells are a unique type of naturally occurring, non-tumorigenic stem cell that can be collected from sources like bone marrow or adipose tissue. When administered, they selectively travel to site...

Typical Protocol

  • This is an experimental therapy currently administered within clinical trials for specific diseases, not as a healthspan protocol.